trending Market Intelligence /marketintelligence/en/news-insights/trending/AAHOcWNDo3xH7UjWVsPESw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Sosei to sell subsidiary to Formosa Laboratories unit

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Sosei to sell subsidiary to Formosa Laboratories unit

Sosei Group Corp. divested its wholly owned subsidiary Activus Pharma to Formosa Pharmaceuticals Inc., a unit of Formosa Laboratories Inc.

Sosei will receive $3.5 million in upfront cash as well as royalties from commercialization of certain products. The company will also receive payments tied to the achievement of certain milestones.

The share transfer agreement will be concluded by Aug. 8, and the closing date of the agreement will be Aug. 10.

Sosei said the transaction will result in a small profit in the current financial year and an additional benefit will be seen from a reduction in operating costs.